Edition:
United Kingdom

Akebia Therapeutics Inc (AKBA.OQ)

AKBA.OQ on NASDAQ Stock Exchange Global Market

6.65USD
15 Feb 2019
Change (% chg)

$0.18 (+2.78%)
Prev Close
$6.47
Open
$6.49
Day's High
$6.73
Day's Low
$6.44
Volume
303,938
Avg. Vol
307,454
52-wk High
$15.34
52-wk Low
$5.20

Chart for

About

Akebia Therapeutics, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of therapeutics based on hypoxia-inducible factor (HIF) biology. The Company's lead product candidate, vadadustat, is indicated for the treatment of anemia in chronic kidney disease (CKD). It is involved in... (more)

Overall

Beta: 1.02
Market Cap(Mil.): $894.46
Shares Outstanding(Mil.): 47.15
Dividend: --
Yield (%): --

Financials

  AKBA.OQ Industry Sector
P/E (TTM): -- 69.44 33.70
EPS (TTM): -3.62 -- --
ROI: -85.01 8.92 14.45
ROE: -147.39 10.08 15.96

Earnings vs. Estimates